Quadrature Capital’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-46,162
Closed -$70.6K – 1616
2026
Q1
$70.6K Sell
46,162
-23,770
-34% -$31.2K ﹤0.01% 1266
2025
Q4
$86.7K Sell
69,932
-18,330
-21% -$25.7K ﹤0.01% 1126
2025
Q3
$180K Buy
+88,262
New +$162K ﹤0.01% 803
2025
Q2
– Sell
-16,077
Closed -$34.2K – 1061
2025
Q1
$34.2K Buy
+16,077
New +$54.8K ﹤0.01% 1005

Other funds holding BMEA

Quadrature Capital's BMEA Position: Q2 2026 in Review

Quadrature Capital sold out of Biomea Fusion (BMEA) in Q2 2026, closing a stake of 46,162 shares — an estimated $70.6K sold.

Quadrature Capital first reported a position in BMEA in Q1 2025 and held it in 4 quarters. The position peaked at $180K in Q3 2025. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Quadrature Capital reported no remaining Biomea Fusion position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 46,162 Biomea Fusion shares in Q2 2026, an estimated $70.6K.
  • Quadrature Capital first reported a position in Biomea Fusion in Q1 2025 and held it in 4 quarters.
  • Quadrature Capital's Biomea Fusion position peaked at $180K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.